| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $3.77B | — | +22.1% |
| Cost of Revenue | $940.0M | — | +44.4% |
| Gross Profit | $2.83B | — | +16.1% |
| R&D Expense | $823.0M | — | +17.1% |
| SG&A Expense | $288.0M | — | +25.8% |
| Operating Income | $503.0M | — | +11.5% |
| Pre-tax Income | $673.0M | — | +21.3% |
| Income Tax | $204.0M | — | +114.7% |
| Net Income | $469.0M | — | +2.0% |
| EPS (Basic) | $0.45 | — | -79.7% |
| EPS (Diluted) | $0.45 | — | -79.5% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $2.70B | -27.5% | -19.8% |
| Accounts Receivable | $1.71B | -34.8% | +26.0% |
| Current Assets | $8.44B | -19.4% | -9.0% |
| Total Assets | $24.38B | -6.4% | +16.3% |
| Current Liabilities | $9.98B | -4.4% | +20.9% |
| Total Liabilities | $12.65B |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $1.67B | — | -0.4% |
| Capital Expenditures | $141.0M | — | -31.2% |
| Investing Cash Flow | -$451.0M | — | -107.8% |
| Financing Cash Flow | -$2.24B | — | -461.8% |
| Free Cash Flow | $1.53B | — | +3.9% |
| +16.8% |
| Stockholders' Equity | $11.73B | -9.5% | +15.7% |